Editorially independent content, supported with advertising
06.22.21
Deborah Ristvedt, DO, and Mark Gallardo, MD, join Inder Paul Singh, MD, to discuss what constitutes controlled glaucoma. How have their perspectives and management strategies evolved?
12.10.21
Dose & Delivery: Defining Target IOP RangesNathan M. Radcliffe, MD; Davinder S. Grover, MD, MPH; and Inder Paul Singh, MD
09.22.21
Dose & Delivery: New Mechanisms of ActionLorraine M. Provencher, MD; Constance O. Okeke, MD, MSCE; and Inder Paul Singh, MD
06.22.21
Dose & Delivery: Defining Controlled GlaucomaDeborah Ristvedt, DO; Mark Gallardo, MD; and Inder Paul Singh, MD
04.16.21
Dose & Delivery: Evolutions in Glaucoma ManagementNathan Radcliffe, MD; Steven R. Sarkisian Jr, MD; and Inder Paul Singh, MD